{"id":"W4315780755","doi":"10.1136/jitc-2022-006136","title":"Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metastatic pancreatic ductal adenocarcinoma and other solid tumors","year":2023,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Medicine; Nivolumab; Internal medicine; Oncology; Pharmacodynamics; Colorectal cancer; Response Evaluation Criteria in Solid Tumors; Cohort; Pancreatic cancer; Gastroenterology; Cancer; Phases of clinical research; Pharmacokinetics; Clinical trial; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001506236,0.001304804,0.001482825,0.000315246,0.0005364236,0.0007619569,0.0006845585,0.001048478,0.003134623],"category_scores_gemma":[0.0007507066,0.0006974606,0.0009958545,0.0002509168,0.0007933186,0.0008326724,0.0003145792,0.002751135,0.0007534777],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008012899,"about_ca_system_score_gemma":0.001349247,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006745826,"about_ca_topic_score_gemma":0.001970687,"domain_scores_codex":[0.9995858,0.0001754806,0.00002003362,0.00009003175,0.00003806589,0.00009060921],"domain_scores_gemma":[0.9992478,0.00009200357,0.0001668434,0.00005464002,0.0000649393,0.000373774],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7605396,0.1181518,0.01170408,0.0005435603,0.001257872,0.0001653395,0.0004265279,0.001194658,0.04859016,0.0001550539,0.002294409,0.05497701],"study_design_scores_gemma":[0.3627874,0.6176557,0.01389032,0.0000225155,0.0003451657,0.0001581427,0.0000939152,0.0007358839,0.002936403,0.0001071041,0.001248342,0.00001909976],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996658,0.0006270999,0.0002844539,0.0001579082,0.00005070313,0.001307804,0.0003122989,0.00004788515,0.0005537885],"genre_scores_gemma":[0.9946074,0.0003920699,0.001050928,0.0003591641,0.00008664486,0.001898065,0.0005590486,0.00001544505,0.001031212],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003134623,"threshold_uncertainty_score":0.0104863,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03232948702170655,"score_gpt":0.3487401860462075,"score_spread":0.3164106990245009,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}